Tong Ren Tang Product Suspected of Fraud? Official Response: Orders to Halt Distribution, Legal Action Against Involved Company

Deep News12-15

On December 15, Tong Ren Tang Health issued a statement addressing recent media reports alleging false labeling of a product named "99% High-Purity Antarctic Krill Oil." The product was labeled as manufactured by Anhui Habo Pharmaceutical Co., Ltd. and distributed by Beijing Tong Ren Tang (Sichuan) Health Pharmaceutical Co., Ltd. (referred to as "Sichuan Health Pharmaceutical").

In response, the company immediately instructed Sichuan Health Pharmaceutical to cease distribution of the product and initiated a full-scale investigation and traceability process.

The statement clarified that the product had unauthorized prominent use of the "Beijing Tong Ren Tang" branding, which constitutes a legal violation. Tong Ren Tang has initiated legal proceedings against the involved company to protect the rights of consumers and the enterprise.

"We solemnly pledge to strengthen management and work alongside consumers and stakeholders to firmly oppose any actions that jeopardize consumer health, corporate reputation, or legal rights," the statement emphasized. "We also urge consumers to purchase 'Beijing Tong Ren Tang' products exclusively through official channels and verify the 'Tong Ren Tang' double-dragon logo trademark to avoid potential harm."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment